Market Cap : 6.88 M | Enterprise Value : 6.75 M | P/E (TTM) : | P/B : |
---|
OTCPK:ICOTF has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
OTCPK:ICOTF has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, iCo Therapeutics's enterprise value is $6.75 Mil. iCo Therapeutics's Revenue for the trailing twelve months (TTM) ended in Sep. 2020 was $0.00 Mil. Therefore, iCo Therapeutics's EV-to-Revenue for today is .
During the past 13 years, the highest EV-to-Revenue of iCo Therapeutics was 761.00. The lowest was -12.50. And the median was 59.70.
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
As of today (2021-01-22), iCo Therapeutics's stock price is $0.047100. iCo Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 was $0.00. Therefore, iCo Therapeutics's PS Ratio for today is .
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
* The bar in red indicates where iCo Therapeutics's EV-to-Revenue falls into.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
iCo Therapeutics's EV-to-Revenue for today is calculated as:
EV-to-Revenue | = | Enterprise Value (Today) | / | Revenue (TTM) |
= | 6.751 | / | 0 | |
= |
iCo Therapeutics's current Enterprise Value is $6.75 Mil.
iCo Therapeutics's Revenue for the trailing twelve months (TTM) ended in Sep. 2020 was 0 (Dec. 2019 ) + 0 (Mar. 2020 ) + 0 (Jun. 2020 ) + 0 (Sep. 2020 ) = $0.00 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
iCo Therapeutics's PS Ratiofor today is calculated as:
PS Ratio | = | Share Price (Today) | / | Revenue per Share (TTM) |
= | 0.047100 | / | 0 | |
= |
iCo Therapeutics's share price for today is $0.047100.
iCo Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 was 0 (Dec. 2019 ) + 0 (Mar. 2020 ) + 0 (Jun. 2020 ) + 0 (Sep. 2020 ) = $0.00.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
No Headline